Latest Forum Topics /
Riverstone
Last:0.6
![]() |
![]() |
Riverstone go go go!
|
|||||
ttbanthony
Veteran |
04-Dec-2021 13:21
|
||||
x 0
x 0 Alert Admin |
Those who want to sell, just let them sell
Those who want to short, let them short This company has got solid fundamentals. I rank it on par with TG. This will come back hard.
|
||||
Useful To Me Not Useful To Me | |||||
sutiono
Veteran |
04-Dec-2021 13:02
|
||||
x 0
x 0 Alert Admin |
Latest CIMB research report already said many distrubutors had already started to secure orders for deliveries in Dec and beyond .and also high lighted that clean room glove still can command USD120/1000pieces. . So  the CR segment is still going strong as ever. | ||||
Useful To Me Not Useful To Me | |||||
|
|||||
Longtermer
Elite |
04-Dec-2021 12:56
Yells: "A disciplined investor is a wealthy investor" |
||||
x 0
x 0 Alert Admin |
 
 
 
UOB rev, profits figures are out by a mile. Check the analyst estimates before calling for sell. 
2021 3qtr profits Rm1.31b (actual)
2021 FY profits Rm1.6b (likely)
 
UOB 2021 FY profits Rm 1.42b (really?)
UOB 2022 profits Rm 504m (joking??)
Using these figures, TP is 68c. Lets see RS results next month. Anyway, their disclaimer is " subject in spike in cases and high ASPs for clean room gloves" Dyodd is best.
 
|
||||
Useful To Me Not Useful To Me | |||||
Godwinlow
Elite |
04-Dec-2021 12:56
|
||||
x 0
x 0 Alert Admin |
Gloves &ndash Neutral (top pick: Riverstone) The recently discovered Omicron variant of Covid-19 triggered another share price rally for glovemakers over the past week, as concerns rise over another potential wave of outbreak. From our conversation with glovemakers, we gather that demand for healthcare gloves have steadily improved in late 4QCY21F, with distributors turning more active in placing orders for delivery in Dec and beyond. This was mainly due to a combination of 1) low inventory holding (distributors and end-customers have been cautious in their procurement over the past six months), and 2) stabilisation of ex-factory prices driving improvements to distribution margins. We expect the production utilisation rate of both Riverstone (RSTON SP, Add, TP: S$1.20) and UG Healthcare (UGHC SP, Add, TP: S$0.42) to return to an optimal level of c.90% by 1QCY22F. Industry ex-factory prices for nitrile healthcare gloves have declined to c.US$28-34/carton for Nov and Dec shipments, according to findings from our channel checks. This is significantly lower than the peak levels of c.US$100/carton seen in early 2Q21, though still higher than pre- pandemic pricing of c.US$20/carton, mainly due to higher raw material prices. We expect ex-factory prices to decline at a gradual pace hereon, tracking the easing of raw material prices, as ex-factory margins have returned to a more normalised level of c.20% (pre-Covid level: c.15%). Meanwhile, we expect cleanroom glove prices to remain healthy at c.US$120/carton in 4QCY21F, driven by continued strong demand by the electronics and pharmaceutical industries. We maintain Add calls on both RSTON and UGHC. While the ASP declines point to a weaker earnings profile (on a yoy basis) for glovemakers for CY22F, we continue to like RSTON and UGHC given their relative resilience vs. other glovemakers. RSTON stands out with its cleanroom capability, which contributed 20% to its volume and 50% to its gross profit pre-pandemic. UGHC is also uniquely positioned given its original brand manufacturer (OBM) business model, which allows the company a relatively sticky pricing profile as it deals directly with end-consumers in the various countries it has expanded its distribution network to. We believe RSTON&rsquo s valuation is especially attractive &ndash it trades at 9.8x CY23F P/E, while backed by net cash of S$0.39/share (55% of its market cap). We expect back-loaded dividend payout for FY21F (RM0.38 per share) to be the support for its share price. |
||||
Useful To Me Not Useful To Me | |||||
Godwinlow
Elite |
04-Dec-2021 12:46
|
||||
x 0
x 0 Alert Admin |
SINGAPORE &mdash The new Covid variant omicron will likely &ldquo overwhelm the whole world&rdquo in the coming months, according to a Singapore-based infectious disease doctor. While vaccines against the strain can be developed quickly, they need to be tested over three to six months to prove that they can provide immunity against the variant, Dr.  Leong Hoe Nam of Mount Elizabeth Novena Hospital said Wednesday.  
&ldquo But frankly, omicron will dominate and overwhelm the whole world in three to six months,&rdquo he told CNBC&rsquo s  &ldquo Street Signs Asia.&rdquo Delta, the strain that is  currently accounts for 99%  of Covid infections,  started becoming more common in the Indian state of  Maharashtra in March 2021,  and  was dominant globally by July, according to Reuters. Moderna  CEO Stephane Bancel on Monday said it will  take months to develop and ship a vaccine that specifically targets the omicron variant. Pfizer  CEO Albert Bourla also said  shots could be ready in less than 100 days, or slightly over three months. &ldquo Nice idea, but honestly, it is not practical,&rdquo Leong said of a vaccine that specifically targets omicron. &ldquo We won&rsquo t be able to rush out the vaccines in time and by the time the vaccines come, practically everyone will be infected [with] omicron given this high infectious and transmissibility.&rdquo  
Experts don&rsquo t know exactly how contagious the highly mutated omicron  variant is, but the virus&rsquo spike protein &mdash which binds to human cells &mdash has mutations associated with higher transmission and a decrease in antibody protection. &ldquo The profile of the mutations strongly suggest that it&rsquo s going to have an advantage in transmissibility and that it might evade immune protection that you would get,&rdquo U.S. infectious disease expert Dr. Anthony Fauci  told NBC&rsquo s &ldquo Meet the Press&rdquo on Sunday. Protection from current vaccinesThat said, some doctors believe that the existing vaccines will be able to provide some protection against the new variant. Our bodies generate a &ldquo whole host of different antibodies&rdquo in response to vaccines, said Dr. Syra Madad, a fellow at the Belfer Center for Science and International Affairs. &ldquo I do think that our current vaccines will hold up to a certain extent, with this new variant,&rdquo she told CNBC&rsquo s  &ldquo Capital Connection&rdquo   on Wednesday, noting that the vaccines were able to provide protection against delta. &ldquo It may reduce vaccine effectiveness by a couple of notches, but that is yet to be seen,&rdquo she said. Current vaccines, along with boosters should still provide a &ldquo good level of protection,&rdquo she added. Leong agreed that a three-dose vaccine regimen would likely protect against severe disease, but pointed out that many countries still have low vaccination rates. He said omicron is &ldquo threatening the whole world&rdquo with a sudden surge in cases, and health-care systems could be overwhelmed, even if only 1% or 2% of the cases end up in hospital. Omicron was first detected in South Africa and was designated a variant of concern by the WHO last week. It has since been reported in  several other places, including Hong Kong, the Netherlands and Portugal. For now, however, Leong said we should continue to roll out vaccinations, keep our distance, wear masks, and not be overly concerned. Madad echoed the same sentiment. &ldquo We continue to do the Covid-19 prevention measures on an ongoing basis,&rdquo she said. &ldquo Layering it up is really the best approach here.&rdquo &mdash CNBC&rsquo s Saheli Roy Choudhury, Spencer Kimball and Yen Nee Lee contributed to this report. |
||||
Useful To Me Not Useful To Me | |||||
|
|||||
Godwinlow
Elite |
04-Dec-2021 12:43
|
||||
x 0
x 0 Alert Admin |
It' s nice to debate and hear different views.  | ||||
Useful To Me Not Useful To Me | |||||
Godwinlow
Elite |
04-Dec-2021 12:42
|
||||
x 0
x 0 Alert Admin |
Hear all your views. Let' s wait one or two weeks more when it' s more visible  | ||||
Useful To Me Not Useful To Me | |||||
vix787
Member |
04-Dec-2021 12:37
|
||||
x 0
x 0 Alert Admin |
Indeed. Old TP all that were pre Omicron.
|
||||
Useful To Me Not Useful To Me | |||||
|
|||||
ttbanthony
Veteran |
04-Dec-2021 12:08
|
||||
x 0
x 0 Alert Admin |
Relax
Why selling into old tp Re rating coming Dbs and cimb tp $1.20 Why mkt pay attention to low tp only? 🤔 Tg results n outlook next week should serve as bel weather
|
||||
Useful To Me Not Useful To Me | |||||
Stocky901
Supreme |
04-Dec-2021 12:01
|
||||
x 0
x 0 Alert Admin |
OMG. If down 25% means tp is $0.51. Short next week very good kopi.. 😋 😋
|
||||
Useful To Me Not Useful To Me | |||||
ttbanthony
Veteran |
04-Dec-2021 10:35
|
||||
x 0
x 1 Alert Admin |
Bro. Agree with you both hands up.
The progression is always like this: Mild > hospitalised > Critical ICU > bye bye Now stage one and two. Wait a few more weeks. Sure have a lot of cases How can omicron virus be milder when it has more than 40 spikes? Our home bred Dr Hoe Nam already hinted the severity. His tone and body language are quick worrying. Go watch.
|
||||
Useful To Me Not Useful To Me | |||||
msksmsks
Elite |
04-Dec-2021 09:58
|
||||
x 1
x 1 Alert Admin |
Bro
If high hospitalization rates occurs, it's already bad enough. I do not wish any fatality or someone's death to enrich ourselves... RS biz model is resilient serving the clranroom of semicon and healthcare. This lucrative sector is one big contribution . Cheers
|
||||
Useful To Me Not Useful To Me | |||||
|
|||||
Longtermer
Elite |
04-Dec-2021 09:38
Yells: "A disciplined investor is a wealthy investor" |
||||
x 0
x 0 Alert Admin |
Number of deaths is related to number of covid cases. Current Omicron cases are still v low compared with Delta variants. Hope for the best while preparing for the worse.   
|
||||
Useful To Me Not Useful To Me | |||||
ttbanthony
Veteran |
04-Dec-2021 09:33
|
||||
x 0
x 0 Alert Admin |
Bro. Not yet.
Of course we don wish such fatality but objectively fatality will definitely happen. Any variant will cause fatality. Even the common flu when strike the weakest, will cause death. Omicron plus delta, watch the new wave. Now hitting west. Don forget the Winter Olympics. This may become a Winter Omicropics. And China will see its new wave after Wuhan. The omicron plus delta May be more devastating as unlike the first few waves concentrating on certain regions such as USA and India, this latest wave will be more global more wide spread.
|
||||
Useful To Me Not Useful To Me | |||||
Godwinlow
Elite |
04-Dec-2021 02:04
|
||||
x 0
x 0 Alert Admin |
higher transmissibility, no deaths. Not lethal
|
||||
Useful To Me Not Useful To Me | |||||
Godwinlow
Elite |
04-Dec-2021 02:03
|
||||
x 0
x 0 Alert Admin |
GENEVA] The World Health Organization said Friday it had not seen any reports of deaths relating to the new Omicron variant of Covid-19. The WHO said it was collecting evidence about the variant of concern (VOC), as countries around the world scramble to stop it from spreading. But despite a growing number of countries registering infections with the new variant, no deaths have yet been reported to the UN health agency.  
 
" I have not seen reports of Omicron-related deaths yet," WHO spokesman Christian Lindmeier told reporters in Geneva. " We' re collecting all the evidence and we will find much more evidence as we go along. " The more countries... keep testing people, and looking specifically into the Omicron variant, we will also find more cases, more information, and, hopefully not, but also possibly deaths." While Omicron has rattled the world, Lindmeier also urged people to be mindful of the Delta variant, which accounts for 99.8 per cent of sequences uploaded to the GISAID global science initiative with specimens collected in the last 60 days.  
 
" Omicron may be on the rise, and we may come to a point where it takes over to be the dominant variant, but at this point, the very dominant variant remains Delta," he stressed. Lindmeier added: " The restrictions that were put into place in many countries just two weeks ago - economical closures again, lockdowns in some areas, closures of Christmas markets in parts of Europe - this was done before Omicron because of a rise of Delta cases. Let' s not lose sight of this." The spokesman urged people to use proven measures protect themselves against Delta - and thereby against Omicron. The WHO has said it will take several weeks to get a full picture of the transmissibility and disease severity of Omicron, and to assess how vaccines, tests and treatments hold up against the new variant.  
 
As Omicron spreads, pieces of information are emerging from various countries. " What we need to do is we need to take all these observations, assessments and tests and get this information together and then have the experts look at it, carefully weigh it and come up with the assessment. That will still take some time," said Lindmeier. " Preliminary data show that there is higher transmissibility. But that' s basically all we have so far."   |
||||
Useful To Me Not Useful To Me | |||||
Godwinlow
Elite |
04-Dec-2021 01:21
|
||||
x 0
x 0 Alert Admin |
Hate to say. But UOB was right about their price target
|
||||
Useful To Me Not Useful To Me | |||||
lukewong82
Master |
04-Dec-2021 00:51
|
||||
x 2
x 0 Alert Admin |
Back in November, UOB already downgrade RS to $0.68. So no surprise that the share price reached sub $0.68. I wonder why so many so surprise that RS drop below 70 cents. AND whenever analysts give a certain target price, it means can be worse. So if target price is $0.68, it means the share price still has room to drop.. maybe to below $0.60. Usually the target price is higher than the trading price by 20-30% for most counters.
|
||||
Useful To Me Not Useful To Me | |||||
lukewong82
Master |
04-Dec-2021 00:47
|
||||
x 0
x 0 Alert Admin |
![]() Riverstone - UOB Kay Hian 2021-11-11: 3Q21 Results In Line But Expect A Sharp Moderation Going Forward | SGinvestors.io - Where SG Investors Share |
||||
Useful To Me Not Useful To Me | |||||
Godwinlow
Elite |
04-Dec-2021 00:43
|
||||
x 0
x 0 Alert Admin |
This is really like a gamble. Gambling this omicron will cause hospitalisation in the near future, despite having reports saying it have mild cases. Mild cases no gloves needed. Hospitalisation needs glove. 
|
||||
Useful To Me Not Useful To Me |